SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-20-006255
Filing Date
2020-12-11
Accepted
2020-12-11 16:53:29
Documents
1
Period of Report
2020-12-09

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3691
  Complete submission text file 0001062993-20-006255.txt   5064
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Issuer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address
Boston Megan (Reporting) CIK: 0001808923 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39267 | Film No.: 201384075